CD4 and neoplasm: To investigate the impact of the CD80 deactivation in tumor cells on anti-tumor immune reactions, we depleted CD4+, CD8+, natural killer (NK) 1.1+ cells, or macrophages in mice bearing TC-1- and TC-1/dCD80-1-induced tumors (Figure 3).